Is it happening? How will it work? What can you expect? The AOA fielded members’ questions about Congress’ efforts to create a Medicare vision benefit, providing the latest updates on a fluid situation.
Advancing Optometry: State Advocacy Summit 2021, Aug. 30-31, is a virtual opportunity for state advocacy volunteers and leaders, and optometry’s advocates, to collaborate on best practices.
Virtual interviewing has allowed employers to connect to a broader pool of applicants from locations nationwide—get tips for employers and applicants for a stellar virtual interview.
With the Department of Veterans Affairs decision to modernize its electronic health record (EHR) system and its desire to standardize processes, procedures, data and coding, formation of new practice standards is being proposed for all non-MD/DO specialties—including doctors of optometry.
The AOA is hosting a profession-wide videoconference, Thursday, July 29, to discuss rapidly developing legislation to expand Medicare benefits and is seeking members’ input to inform advocacy.
Children’s vision was already a public health concern for the AOA. But then the COVID-19 pandemic happened, and doctors of optometry are increasingly alarmed by the growing prevalence of eye conditions exacerbated by remote learning due to the crisis. The AOA is lending its voice as a leader in eye health and vision care through a yearlong conversation on children’s eye health at a critical juncture.
Regulators have taken a “hands-off” approach to this key ACA provision for a decade, but now members of Congress encourage full implementation of the law as originally intended.
“Interseasonal viral activity” is up as people relax COVID-19 mask and distancing requirements, the CDC says, while a new pandemic variant proliferates—what doctors should know.
COVID-19 accelerated telemedicine’s years-long sprawl in health care, and now experts ponder whether telemedicine’s emergency expansion can be rolled back—or if it’s solidified its place in the new normal. This raises the question: Where’s the line between technology as a tool for patient care and corporate profit?